About the International Journal of Inflammation Research
A multidisciplinary platform advancing research on inflammation mechanisms, clinical manifestations, therapeutic interventions, and translational applications across all domains of human health
Our Mission
IJIR aims to create an international network of scientists, clinicians, and educators dedicated to advancing inflammation research. By providing a platform for high-quality publications, we accelerate the translation of inflammatory science from bench to bedside.
We prioritize research that deepens mechanistic understanding, identifies novel biomarkers, evaluates therapeutic interventions, and addresses the societal burden of inflammation-related diseases. Our multidisciplinary approach ensures that insights from diverse fields converge to solve complex inflammatory challenges.
Open Access Commitment
All IJIR articles are published under Creative Commons licenses, ensuring that research findings reach clinicians, researchers, educators, and policymakers without barriers. Our open access model accelerates knowledge transfer and supports evidence-based decision-making worldwide.
Authors retain copyright while granting broad reuse rights, enabling their work to be cited, taught, and applied in derivative research. This accessibility promotes collaboration across institutions, disciplines, and geographic boundaries.
IJIR publishes research across the full spectrum of inflammation science. Our scope encompasses cellular mechanisms, organ-specific inflammatory conditions, systemic inflammation, and therapeutic strategies. We welcome both fundamental investigations and applied clinical studies that advance the field.
Pathophysiology, resolution mechanisms, transition from acute to chronic states, and inflammatory mediator dynamics
Signaling pathways, transcription factors, cytokine networks, inflammasome activation, and epigenetic regulation
Immune cell function, hypersensitivity reactions, autoimmune inflammation, and immunomodulation
Hepatitis, dermatological inflammation, mastitis, respiratory inflammation, neuroinflammation, and cardiovascular inflammation
Drug development, natural products, biologics, small molecules, and combination therapy strategies
Patient stratification, biomarker validation, treatment efficacy, disease progression monitoring, and quality of life
Inflammatory bowel disease, rheumatoid arthritis, atherosclerosis, cancer-related inflammation, metabolic inflammation
Cytokines, chemokines, acute phase proteins, lipid mediators, and novel diagnostic/prognostic markers
Necrosis, apoptosis, pyroptosis, ferroptosis, and their roles in inflammatory pathology
IJIR is committed to providing authors with a transparent, efficient, and supportive publication experience. Our editorial team works diligently to ensure timely peer review without compromising scientific rigor.
Use our online submission form, Manuscript Zone portal, or email to [email protected]
Initial screening for scope alignment, ethical compliance, and methodological soundness
Expert reviewers evaluate scientific validity, novelty, and significance; authors receive constructive feedback
Authors address reviewer comments; revised manuscripts undergo final editorial review
Rapid online publication with DOI assignment, indexing, and global visibility
To ensure smooth processing, authors should prepare manuscripts according to IJIR's formatting and ethical standards. Detailed instructions are available in our comprehensive Instructions for Authors guide.
Manuscript Types
- Original Research Articles: Full reports of novel experimental or clinical investigations
- Reviews: Comprehensive syntheses of current knowledge on specific inflammation topics
- Short Communications: Concise reports of preliminary or focused findings
Ethical Requirements
- Institutional review board approval for human studies
- Ethical committee approval for animal research
- Informed consent documentation
- Conflict of interest disclosure
- Adherence to reporting guidelines (CONSORT, ARRIVE, etc.)
IJIR operates an article processing charge (APC) model to sustain high-quality peer review, editorial operations, and open access dissemination. APCs are charged only upon acceptance, ensuring authors invest only in successfully peer-reviewed manuscripts.
IJIR's editorial board comprises internationally recognized experts in inflammation research, immunology, pharmacology, and clinical medicine. Our editors bring specialized knowledge across inflammation subfields, ensuring that each manuscript receives informed, constructive evaluation.
- Peer-reviewed selection of section editors with documented expertise
- Geographic diversity representing research centers worldwide
- Commitment to ethical publishing practices and scientific integrity
- Transparent conflict of interest policies for all editorial decisions
- Continuous professional development in publication ethics and best practices
"We were truly pleased to publish our article in International Journal of Inflammation Research. The entire process, from submission to publication, was very smooth and fast and the editorial staff was extremely helpful and efficient. We found each step in the submission and publishing process to be expertly handled. We received tough reviews, which allowed us to greatly improve the paper, and this was followed up with very prompt publication and excellent access across the journal website. I certainly hope to publish more of our work in International Journal of Inflammation Research and will recommend it to my colleagues."
Join the IJIR Community
Contribute to advancing inflammation science by sharing your research with a global audience. IJIR provides the platform, expertise, and visibility your work deserves.
